KELLY SCOTT: Open Payments
NPI 1457406100 · BEAVER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,241 in 87 payments from 19 companies in 2025. Trend: 2023 $1,318 · 2024 $1,687 · 2025 $2,241
Food & beverage: $2,241
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $392 |
| Alkermes, Inc. | 19 | $375 |
| Otsuka America Pharmaceutical, Inc. | 9 | $265 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $251 |
| E.R. Squibb & Sons, L.L.C. | 4 | $211 |
| Braeburn Inc. | 9 | $182 |
| Teva Pharmaceuticals USA, Inc. | 7 | $151 |
| Indivior Inc. | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| Janssen Pharmaceuticals, Inc | 2 | $52 |
Products named: VRAYLAR, REXULTI, CAPLYTA, COBENFY, BRIXADI, LYBALVI, AUSTEDO XR, VIVITROL.
Industry payments across PA — which companies pay providers there.
